Name: Barbara Malene Fischer (e-mail)
Title: MD,PhD, DMSc
• Chief Physician, Dept. of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet
• Associate Professor, Copenhagen University, Faculty of Health
- Area of interest
- Activities
- Education
- List of publications
- CV
Barbara Fischer is a medical doctor specializing in clinical physiology and nuclear medicine, including app. one year of training in clinical oncology. Since 2001 she has been doing research in the field of PET/CT and oncology, with a special focus on lung cancer diagnosing and staging.
Barbara Fischer’s research in this field span from pre-clinical in-vitro studies to large scale randomized clinical trials. Henceforth Barbara Fischer continues her research in the field of nuclear medicine and oncology (especially lung cancer and head&neck cancer) but now with focus on radiotherapy planning, therapy evaluation, implementation of PET/MRI and procurement of new knowledge that can help bridging the gap between molecular biology, imaging and clinical practice.Young EANM Delegate (European Association of Nuclear Medicine)
WG is the umbrella organisation of junior doctors’ associations from all over Europe. At present, WG represents the residents of 26 European countries. WG’s initial objectives are safeguarding the interests of residents in Europe, improving relationships between its member organisations and narrowing the gap between residents in different countries.
Head of YNK (Yngre Nuklearmedicineres Klub)
YNK is a group of junior doctors in the specialty Clinical Physiology and Nuclear medicine. It is created to strengthen the solidarity among the members, and to exchange knowledge.
Boardmember of Danish Society of Clinical Physiology and Nuclear Medicine
"Skeptica"
Education:
1995-2002 Medicine, Faculty of Health, Copenhagen University
2003-2006 PhD-studies, Rigshospitalet and Copenhagen University
2009-2013 Specialization in Clinical Physiology and Nuclear Medicine
Ladefoged CN, Hansen AE, Keller SH, Fischer BM, Rasmussen JH, Law I, Beyer T, Kjær A, Højgaard L, Lauze F, Andersen FL. Improving quality and accuracy of PET/MR imaging of the brain, head and neck through inpainting of dental artifacts. Submitted Jan 2014.
Rasmussen J, Vogelius IR, Fischer BM, Friborg J, Aznar MC, Persson GF, Håkansson K, Kristensen CA, Bentzen S, Spect L. Prognostic value of 18F-Fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma. Head&Neck, 2014 May 7. doi: 10.1002/hed.23745.
Langer NH, Christensen TN, Langer S, Kjær A, Fischer BM. PET/CT in therapy evaluation of patients with lung cancer. Expert Rev Anticancer Ther, May;14(5):595-620
Danielsen M, Højgaard L, Kjær A, Fischer BM. Positron Emission Tomography in the Follow-up of Cutaneous Malignant Melanoma Patients: a Systematic Review. Am J Nucl Med Mol Imaging, 2013:4;17-28.
Harders S, Balyasnikova S, Fischer BM. Functional Imaging in Lung Cancer. Clinical Physiology and Molecular Imaging, accepted for publication oct 2013
Søgaard R, Fischer BM, Mortensen J, Rasmussen TR, Lassen U. The optimality of different strategies for supplemental staging non-small-cell lung cancer: a health economic decision analysis. Value of Health 2013;16:57-65. Balyasnikova S, Löfgren J, de Nijs R, Zamogilnaya Y, Højgaard L, Fischer BM. PET/MR in oncology. An introduction with focus on MR and future perspectives for oncology imaging. Am J Nucl Med Mol Imaging 2012;2(4):458-74 Fischer BM, Højgaard L. PET/MR-skanning. Ugeskr Læger 2012;174(12):787
Fischer BM, Mortensen J. The Role of Positron Emission Tomography (PET) for evaluation of Lung Nodules and Staging Lung Cancer. Curr Resp Care Reports, invited review, submitted september 2011
Vach W, Høilund-Carlsen PF, Fischer BM, Gerke O, Weber W. How to study optimal timing of PET/CT for monitoring of cancer treatment. Am J Nucl Med Mol Imaging 2011;1(1):54-62
Bjerregaard JK, Fischer BM, Vilstrup M, Petersen H, Mortensen, Hansen, Asmussen, Pfeiffer P, Høilund-Carlsen, PF. Feasibility of FDG-PET/CT imaging during concurrent chemo-radiotherapy in patients with locally-advanced pancreatic-cancer. Acta Oncologica. May 2011 (Epub ahead of print)
Søgaard R, Fischer BM, Mortensen J, Højgaard L, Lassen U. Preoperative staging of lung cancer with PET-CT: Cost-effectiveness evaluation alongside a randomised controlled trial. Eur J Nucl Med Mol Imaging. 2011 May;38(5):802-9
Fischer BM, Mortensen J, Hansen H, Vilmann P, Larsen SL et al. Multimodality approach to mediastinal staging in non-small call lung cancer. Faults and benefits of PET-CT. Thorax. 2011 Apr;66(4):294-300
Fischer BM, Lassen U, Mortensen J, Larsen SS, Loft A. Pre-operative staging of lung cancer with combined PET-CT. N Engl J Med July 2009;361:32-9
Skov BG, Fischer BM, Pappot H. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer 2008 Jan;59(1):88-94.
Mortensen J, Fischer BM. Nuclear medicine techniques and applications in pulmonology with a spezial emphasis on PET. Turkiye Klinikleri J Int Med Sci, 2006, 2(32):68-74.
Fischer BM, Mortensen J, Langer SW, Loft A, Berthelsen AK, Daugaard G, Hansen HH. PET/CT imaging in response evaluation of patients with small cell lung cancer. Lung Cancer 2006;54:41-49.
Fischer BM, Mortensen J, Langer SW, Loft A, Berthelsen AK, Petersen BL, Daugaard G, Lassen U, Hansen HH. Staging small cell lung cancer – the value of PET/CT, bone scintigraphy and immunocytochemistry of bone marrow. A prospective study. Annals of Oncology Advanced Access, published October 23, 2006.
Fischer BM, Mortensen J. The future in diagnosis and staging of lung cancer - Positron Emission Tomography. Respiration 2006;73(3):267 – 276
Fischer BM, Olsen MWP, Ley CD, Klausen TL, Mortensen J, Højgaard L, Kristjansen PEG. How few cancer cells can be detected by positron emission tomography? A frequent question addresses by an in vitro study. Eur J Nucl Med Mol Imaging 2006;33:697-702
Almasi CE, Fischer BM, Skuladottir H, Nøttrup T, Pappot H. Et bedre liv med lungekræft – myter og facts. Månedsskrift for Praktisk Lægegerning 2005;83(11): 1371-81
Pappot H, Fischer BM, Elberling C, Skuladottir H, Nøttrup T. Lungekræft – en teknologisk udfordring II. Nye behandlingstiltag. Ugeskrift for Læger 2004;166:4243-5
Nøttrup T, Fischer BM, Elberling C, Skuladottir H, Pappot H. Lungekræft – en teknologisk udfordring I. Diagnostik og stadieinddeling. Ugeskrift for Læger 2004;166:4241-3
Vansteenkiste J, Fischer BM, Dooms C, Mortensen J. Positron emission tomography in the prognostic and therapeutic evaluation of lung cancer: a systematic review. Lancet Oncology 2004; 5:531-40
Bach-Gansmo T, Bogsrud TV, Aas M, Fischer BM. Positron emisjonstomografi (PET) ved lungekreft. Tidsskr Nor Lægeforen 2004; 124:1088-89
Fischer BM, Mortensen J. Lungecancer – Skal man bruge PET? Ugeskrift for Læger 2004; 166:2537-2541.
Fischer BM, Elberling C, Skuladottit H, Nøttrup T, Christensen C, Pappot H. Kvinder og lungekræft: epidemiologi, rygning og biologi. Ugeskrift for Læger 2003; 165(47): 4550-2.
Fischer BM, Mortensen J, Dirksen A, Eigtved A, Højgaard L. Positron Emission Tomography of incidentally detected small pulmonary nodules. Nuclear Medicine Communications 2004; 25:3-9
Fischer BM, Mortensen J, Højgaard L. PET in the diagnosis and staging of lung cancer - A systematic, quantitative review of the literature. Lancet Oncology 2001; 2(11):659-666
The Curriculum Vitae can be downloaded here as a *PDF file: Barbara_Malene_Fischer_CV.pdf